CA964193A - Injectable compositions containing salts of l-tetramisole - Google Patents

Injectable compositions containing salts of l-tetramisole

Info

Publication number: CA964193A
Authority: CA; Canada
Prior art keywords: tetramisole; compositions containing; injectable compositions; containing salts; salts
Prior art date: 1969-07-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA088,685A

Other languages

English (en)

Other versions

CA88685S (en

Inventor

Bruce A. Forsyth

David E. Pryor

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Orica Ltd

Original Assignee

Imperial Chemical Industries of Australia and New Zealand Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1969-07-21

Filing date

1970-07-21

Publication date

1975-03-11

1970-07-21 Application filed by Imperial Chemical Industries of Australia and New Zealand Ltd filed Critical Imperial Chemical Industries of Australia and New Zealand Ltd

1975-03-11 Application granted granted Critical

1975-03-11 Publication of CA964193A publication Critical patent/CA964193A/en

Status Expired legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

CA088,685A 1969-07-21 1970-07-21 Injectable compositions containing salts of l-tetramisole Expired CA964193A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
AU5831169		1969-07-21

Publications (1)

Publication Number	Publication Date
CA964193A true CA964193A (en)	1975-03-11

Family

ID=3743604

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA088,685A Expired CA964193A (en)	1969-07-21	1970-07-21	Injectable compositions containing salts of l-tetramisole

Country Status (9)

Country	Link
US (1)	US3670086A (de)
BE (1)	BE753710A (de)
CA (1)	CA964193A (de)
DE (1)	DE2036114C3 (de)
FR (1)	FR2059541B1 (de)
GB (1)	GB1287673A (de)
IE (1)	IE34373B1 (de)
NL (1)	NL165653C (de)
ZA (1)	ZA704419B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4096271A (en) *	1977-08-03	1978-06-20	American Cyanamid Company	Slow release injectable formulations of tetramisole and derivatives in benzyl benzoate
WO2005018551A2 (en)	2003-08-12	2005-03-03	3M Innovative Properties Company	Oxime substituted imidazo-containing compounds
MXPA06002199A (es)	2003-08-27	2006-05-22	3M Innovative Properties Co	Imidazoquinolinas sustituidas con grupos ariloxi o arilalquilenoxi.
CA2537763A1 (en)	2003-09-05	2005-03-17	3M Innovative Properties Company	Treatment for cd5+ b cell lymphoma
CA2540541C (en)	2003-10-03	2012-03-27	3M Innovative Properties Company	Alkoxy substituted imidazoquinolines
US7544697B2 (en)	2003-10-03	2009-06-09	Coley Pharmaceutical Group, Inc.	Pyrazolopyridines and analogs thereof
CA2545774A1 (en)	2003-11-14	2005-06-02	3M Innovative Properties Company	Oxime substituted imidazo ring compounds
CN1906192A (zh)	2003-11-14	2007-01-31	3M创新有限公司	羟胺取代的咪唑环化合物
EP1687307B1 (de)	2003-11-25	2016-01-06	3M Innovative Properties Company	Substituierte imidazoringsysteme und verfahren
WO2005066170A1 (en)	2003-12-29	2005-07-21	3M Innovative Properties Company	Arylalkenyl and arylalkynyl substituted imidazoquinolines
WO2005066169A2 (en)	2003-12-30	2005-07-21	3M Innovative Properties Company	Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
AU2005228150A1 (en)	2004-03-24	2005-10-13	3M Innovative Properties Company	Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en)	2004-06-15	2011-09-13	3M Innovative Properties Company	Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006009832A1 (en) *	2004-06-18	2006-01-26	3M Innovative Properties Company	Substituted imidazo ring systems and methods
US8026366B2 (en)	2004-06-18	2011-09-27	3M Innovative Properties Company	Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US7897609B2 (en)	2004-06-18	2011-03-01	3M Innovative Properties Company	Aryl substituted imidazonaphthyridines
US7915281B2 (en)	2004-06-18	2011-03-29	3M Innovative Properties Company	Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
ES2392648T3 (es)	2004-12-30	2012-12-12	3M Innovative Properties Company	Compuestos quirales sustituidos que contienen un núcleo 1,2-imidazo-4,5-c condensado
ZA200706251B (en) *	2004-12-30	2008-11-26	Coley Pharm Group Inc	Immune response modifier formulations and methods
WO2006074003A2 (en)	2004-12-30	2006-07-13	3M Innovative Properties Company	CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS
AU2006210392A1 (en)	2005-02-04	2006-08-10	Coley Pharmaceutical Group, Inc.	Aqueous gel formulations containing immune response modifiers
AU2006213746A1 (en)	2005-02-11	2006-08-17	Coley Pharmaceutical Group, Inc.	Oxime and hydroxylamine substituted imidazo(4,5-c) ring compounds and methods
WO2006107853A2 (en)	2005-04-01	2006-10-12	Coley Pharmaceutical Group, Inc.	Pyrazolopyridine-1,4-diamines and analogs thereof
AU2006232375A1 (en)	2005-04-01	2006-10-12	Coley Pharmaceutical Group, Inc.	1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
US7906506B2 (en)	2006-07-12	2011-03-15	3M Innovative Properties Company	Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
CN104906036A (zh) *	2015-06-12	2015-09-16	重庆市畜牧科学院	阿魏酸左旋咪唑注射液的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL131034C (de) *	1964-05-11
AU421744B2 (en) *	1967-08-24	1972-02-24	I. C. I. Australia Limited	Chemical process

1970
- 1970-06-26 ZA ZA704419*A patent/ZA704419B/xx unknown
- 1970-07-08 IE IE885/70A patent/IE34373B1/xx unknown
- 1970-07-09 GB GB33395/70A patent/GB1287673A/en not_active Expired
- 1970-07-13 US US54642A patent/US3670086A/en not_active Expired - Lifetime
- 1970-07-16 NL NL7010558.A patent/NL165653C/xx not_active IP Right Cessation
- 1970-07-20 FR FR7026720A patent/FR2059541B1/fr not_active Expired
- 1970-07-20 BE BE753710D patent/BE753710A/xx not_active IP Right Cessation
- 1970-07-21 CA CA088,685A patent/CA964193A/en not_active Expired
- 1970-07-21 DE DE2036114A patent/DE2036114C3/de not_active Expired

Also Published As

Publication number	Publication date
GB1287673A (en)	1972-09-06
BE753710A (fr)	1970-12-31
FR2059541B1 (de)	1974-10-11
ZA704419B (en)	1971-04-28
NL7010558A (de)	1971-01-25
DE2036114B2 (de)	1979-01-18
NL165653C (nl)	1981-05-15
IE34373L (en)	1971-01-21
NL165653B (nl)	1980-12-15
DE2036114A1 (de)	1971-02-04
US3670086A (en)	1972-06-13
FR2059541A1 (de)	1971-06-04
IE34373B1 (en)	1975-04-16
DE2036114C3 (de)	1979-09-13

Publication	Publication Date	Title
CA964193A (en)	1975-03-11	Injectable compositions containing salts of l-tetramisole
CA955390A (en)	1974-10-01	Compositions containing aminopolyureylene resin
ZM4370A1 (en)	1971-02-22	Novel compositions of matter
CA978538A (en)	1975-11-25	Phosphonate compositions
CA923425A (en)	1973-03-27	Compositions containing garcinia acid
IL34089A (en)	1974-05-16	Pharmaceutical compositions containing penicillin or cephalosphorin derivatives
CA927079A (en)	1973-05-29	Pressure-oxidation of metal-sulfur-containing compositions
AU2085570A (en)	1972-04-13	Rubber-polyester compositions
CA979900A (en)	1975-12-16	Dialkyltin salts of substituted pyridine-1-oxides
AU450313B2 (en)	1971-09-16	Injectable oxytetracycline compositions
AU4960269A (en)	1970-07-30	Composition of matter
AU4067468A (en)	1971-01-07	Compositions of matter
AU453663B2 (en)	1972-08-10	Compositions containing n-dioctylethylene-triamines
CA777802A (en)	1968-02-06	Compositions of matter
AU437962B2 (en)	1971-04-22	Compositions of matter
AU456939B2 (en)	1971-11-18	Ester containing composition
AU1292270A (en)	1971-09-30	Improved beverage-forming compositions
AU453959B2 (en)	1972-04-20	Hydroxycitric acid derivatives containing compositions
AU449360B2 (en)	1972-06-22	Stabilizing composition
CA836563A (en)	1970-03-10	Composition of matter
CA796212A (en)	1968-10-08	Stabilized composition of quinonedihalimide compound
CA822730A (en)	1969-09-09	Compositions containing graphite
CA830476A (en)	1969-12-23	Therapeutic compositions containing aminocyclobutanols
AU1240870A (en)	1971-09-16	Injectable oxytetracycline compositions
CA829875A (en)	1969-12-16	Pharmaceutical compositions containing 1-methyl-4-phenyl-4-piperidinol